Comprehensive market analysis

Pharmaceutical market insights with data-driven precision

Pharmaceutical market insights with data-driven precision

Datamonitor Healthcare

Expert intelligence for confident market decisions

Datamonitor Healthcare delivers in-depth, actionable insights to support your commercial strategy. With our expert analysis and interactive tools, you can uncover market trends, identify unmet need, and forecast opportunities for informed decision-making.

Our insights go beyond data, providing meaningful context and implications. Monitor market movements in real time, access patient and sales forecasts, and evaluate competitor strategies, licensing opportunities, and potential partnerships with clarity and precision.

Datamonitor healthcare

Datamonitor Healthcare

by the numbers

Explore

disease categories

0

Monitor

unique drugs
0 +

Uncover

KOL insights
0 +

How Datamonitor Healthcare can help you

Datamonitor Healthcare svg 1 Expert intelligence for confident market decitions REGIONAL ANALYSIS JAPAN (5.7%) EU (20.1%) US (74.1%) THERAPY AREA ANALYSIS DISEASE ANALYSIS REVENUE PATIENTS TOP DRUGS Drug A Drug B Drug C Drug D Drug E Drug F DRUG ANALYSIS Drug A Drug Classification: Biologic Molecule Type: Monoclonal Antibody Disease(s): Multiple Myeloma Target: CD38, Immune System Administration: IV, SQ

1. Gain clarity on market dynamics

Access insights into market opportunities, identify successful and at-risk drug classes, and evaluate the impact of payer pressure and substitution threats.

2. Evaluate the competition

Leverage the proprietary Drug Assessment Model to assess the attractiveness of both marketed and pipeline therapies, helping you stay competitive in a shifting landscape.

Datamonitor Healthcare svg 2 Evaluate the Competition BY AGE & GENDER United States Germany Japan France United Kingdom BY COUNTRY 30-34 35-39 40-44 45-49 50-54 55-59
Datamonitor Healthcare svg 3 Understand Patient Populations and Epidemiology CLINICAL CLINICAL COMMERCIAL COMMERCIAL Drug A Drug B Drug C Drug D Drug E Drug F Drug A Drug B Drug C Drug D Drug E Drug F SELECTED DRUG: Drug A CLINICAL SCORE 68.0 68.5 COMMERCIAL SCORE Efficacy Safety Tolerability Administration route Administration frequency Clinical trial design

3. Understand patient populations and epidemiology

Analyze disease prevalence and incidence with detailed forecasts, broken down by country, age, and gender, to better understand patient demographics and trends.

Need deeper insight into a specific disease area?

Our Disease Report Store offers a growing library of in-depth reports across key indications, designed to support strategic decisions with patient-centric forecasting, epidemiological data, and market context.

Who is Datamonitor Healthcare for?

Discover how Datamonitor Healthcare empowers professionals across pharma, biotech, CROs, professional services, finance and consulting to drive informed decisions.

Competitive Intelligence

Generate accurate product forecasts swiftly, giving you the edge in decision-making.

Market Research

Dive deep into 130+ diseases, enriched with insights from in-house analysts and key opinion leaders for a comprehensive market view.

Portfolio Strategy

Make strategic decisions with confidence using reliable data to target specific markets and optimize your portfolio.

Business Development

Evaluate market potential for in-licensing and out-licensing opportunities, ensuring your compound finds its best market fit.

Consulting / CRO / Agencies

Access granular disease data to enhance RFPs and deliver precise client solutions. Become a disease expert in no time.

Finance & Investment

Identify the right investment opportunities for your portfolio using a unique blend of highly granular data and deep industry expertise.

Personalize your insights with advanced filters

Use customizable filters to explore detailed data on diseases, products, companies, KOL insights, and more — empowering you to quickly find the insights that matter most.

Disease

Gain deep insights into disease states with comprehensive epidemiological data, unmet needs, and treatment landscapes.

Products

Assess product success probabilities and market dynamics for a clear understanding of performance and potential.

Companies

Access expert SWOT analysis on the top 45 companies to inform strategic decisions.

KOL Insights

Tap into Key Opinion Leader insights for strategic perspectives beyond the data.

Thought Leadership

Stay ahead with leading reports, articles, and conference highlights on market trends.

Dashboards

Easily navigate consolidated data for a comprehensive view of key insights.

Ready to see how Evaluate can help you make smarter decisions?

Get in touch with our team to explore the right solutions for your business.